N

Newcastle Private Hospital | Oncology Department

Research site
(Unclaimed)
Location
14 Lookout Road, New Lambton Heights, New South Wales, Australia
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

7 of 12
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy (ATHENA)

This is a Phase 3, randomized, multinational, double-blind, dual placebo-controlled, 4-arm study evaluating rucaparib and nivolumab as maintenance tr...

Active, not recruiting
FIGO Stage III-IV
Newly Diagnosed
Drug: Rucaparib
Drug: Placebo Oral Tablet

This Phase 3 study is designed to compare the efficacy and safety of mirvetuximab soravtansine vs. investigator's choice chemotherapy in patients wit...

Active, not recruiting
Epithelial Ovarian Cancer
Peritoneal Cancer
Drug: Paclitaxel
Drug: Pegylated liposomal doxorubicin

This is an open-label, multicenter, global Phase 2 basket study of entrectinib (RXDX-101) for the treatment of patients with solid tumors that harbor...

Active, not recruiting
Breast Cancer
Melanoma
Drug: Entrectinib

PICCOLO (IMGN853-0419) is a Phase 2 multicenter, open label study designed to evaluate the safety and efficacy of Mirvetuximab Soravtansine in partic...

Active, not recruiting
Peritoneal Cancer
Fallopian Tube Cancer
Drug: Mirvetuximab soravtansine

To determine if the regorafenib and nivolumab combination (RegoNivo) improves overall survival compared with current standard chemotherapy options in...

Enrolling
Gastro-Oesophageal Cancer
Biological: Nivolumab
Drug: Paclitaxel

This is a First-in-Human Phase IA/IB/II open label dose escalation study of intravenous (IV) administration of ONC-392, a humanized anti-CTLA4 IgG1 m...

Enrolling
Salivary Gland Cancer
Adenoid Cystic Carcinoma
Drug: Pembrolizumab
Drug: ONC-392

The purpose of this study is to evaluate the efficacy and safety of selinexor as a maintenance treatment in patients with p53 wt endometrial carcinom...

Enrolling
Endometrial Cancer
Drug: Matching Placebo for selinexor
Drug: Selinexor

Trial conditions

Ovarian Cancer (4 trials)
Fallopian Tube Cancer (3 trials)
Carcinoma (2 trials)
Colorectal Cancer (2 trials)
Endometrial Cancer (2 trials)
Ovarian Epithelial Carci... (2 trials)
Pancreatic Cancer (2 trials)
Salivary Gland Cancer (2 trials)
Adenocarcinoma (1 trial)
Adenoid Cystic Carcinoma (1 trial)

And 16 more

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems